Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinsuke Iida

Showing results (41-50 of 328) with videos related to

Pageof 33
Sort By:
Cancer Science|June 1, 2006
Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell linesTomohiro Kajiguchi, Kazuhito Yamamoto, Shinsuke Iida, et al.
Cancer Science|July 31, 2018
Weekly carfilzomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma: A phase 1 and PK/PD trialDai Maruyama, Kensei Tobinai, Takaaki Chou, et al.
International Journal of Hematology|February 1, 2020
Daratumumab, lenalidomide, and dexamethasone in Japanese patients with transplant-ineligible newly diagnosed multiple myeloma: a phase 1b studyHiroyuki Takamatsu, Shinsuke Iida, Hirohiko Shibayama, et al.
International Journal of Hematology|December 21, 2017
Safety and efficacy of daratumumab in combination with bortezomib and dexamethasone in Japanese patients with relapsed or refractory multiple myelomaShinsuke Iida, Tatsuo Ichinohe, Atsushi Shinagawa, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2015
Screening Performance for Frailty Among Older Patients With Cancer: A Cross-Sectional Observational Study of Two ApproachesToru Okuyama, Koji Sugano, Shinsuke Iida, et al.
Haematologica|April 12, 2005
Global real-time quantification/reverse transcription-polymerase chain reaction for detecting proto-oncogenes associated with 14q32 chromosomal translocation in multiple myelomaEmi Tajima, Miyuki Uranishi, Shinsuke Iida, et al.
Future Oncology (London, England)|November 4, 2022
Practice patterns and outcomes for triple-class exposed patients with relapsed/refractory multiple myeloma in JapanShinsuke Iida, Mayuko Nakakoji, Dionysis Spanopoulos, et al.
Cancer Science|June 21, 2019
Immunohistochemistry for identification of CCND1, NSD2, and MAF gene rearrangements in plasma cell myelomaTakayuki Murase, Masaki Ri, Tomoko Narita, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|March 23, 2023
Two cases of transplant-acquired food allergy who developed resensitization after a negative oral food challengeAkiko Nakaoka, Takayasu Nomura, Kazuyoshi Ozeki, et al.
Japanese Journal of Clinical Oncology|September 17, 2024
COVID-19 in patients receiving treatment at an outpatient chemotherapy unitShiori Kinoshita, Masashi Takemoto, Minami Asaoka, et al.
Pageof 33

Showing results (41-50 of 328) with videos related to

Sort By:
Pageof 33
Cancer Science|June 1, 2006
Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell linesTomohiro Kajiguchi, Kazuhito Yamamoto, Shinsuke Iida, et al.
Cancer Science|July 31, 2018
Weekly carfilzomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma: A phase 1 and PK/PD trialDai Maruyama, Kensei Tobinai, Takaaki Chou, et al.
International Journal of Hematology|February 1, 2020
Daratumumab, lenalidomide, and dexamethasone in Japanese patients with transplant-ineligible newly diagnosed multiple myeloma: a phase 1b studyHiroyuki Takamatsu, Shinsuke Iida, Hirohiko Shibayama, et al.
International Journal of Hematology|December 21, 2017
Safety and efficacy of daratumumab in combination with bortezomib and dexamethasone in Japanese patients with relapsed or refractory multiple myelomaShinsuke Iida, Tatsuo Ichinohe, Atsushi Shinagawa, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2015
Screening Performance for Frailty Among Older Patients With Cancer: A Cross-Sectional Observational Study of Two ApproachesToru Okuyama, Koji Sugano, Shinsuke Iida, et al.
Haematologica|April 12, 2005
Global real-time quantification/reverse transcription-polymerase chain reaction for detecting proto-oncogenes associated with 14q32 chromosomal translocation in multiple myelomaEmi Tajima, Miyuki Uranishi, Shinsuke Iida, et al.
Future Oncology (London, England)|November 4, 2022
Practice patterns and outcomes for triple-class exposed patients with relapsed/refractory multiple myeloma in JapanShinsuke Iida, Mayuko Nakakoji, Dionysis Spanopoulos, et al.
Cancer Science|June 21, 2019
Immunohistochemistry for identification of CCND1, NSD2, and MAF gene rearrangements in plasma cell myelomaTakayuki Murase, Masaki Ri, Tomoko Narita, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|March 23, 2023
Two cases of transplant-acquired food allergy who developed resensitization after a negative oral food challengeAkiko Nakaoka, Takayasu Nomura, Kazuyoshi Ozeki, et al.
Japanese Journal of Clinical Oncology|September 17, 2024
COVID-19 in patients receiving treatment at an outpatient chemotherapy unitShiori Kinoshita, Masashi Takemoto, Minami Asaoka, et al.
Pageof 33